Navigation Links
Regenstrief Institute president to receive national recognition
Date:10/19/2011

INDIANAPOLIS William M. Tierney, M.D., president and CEO of the Regenstrief Institute, will receive the 2011 Morris F. Collen Award from AMIA, the largest international professional biomedical informatics association, at the opening plenary session of AMIA's 35th Annual Symposium on Biomedical and Health Informatics in Washington, D.C. on Oct. 23.

On Oct. 26, Dr. Tierney, who also is the associate dean for clinical effectiveness research at the Indiana University School of Medicine, will present the symposium's closing keynote address.

Dr. Tierney is being honored with the Collen Award for his "persistent efforts to advance the field of biomedical and health informatics, and thus, to exalt data-driven and computer-assisted health care as the norm, both in the United States and globally."

An international leader in biomedical informatics and health services research, Dr. Tierney studies the effects of computer-based interventions to improve health care quality and lower costs of health care delivery. He has received more than $40 million as principal investigator in grants and contracts from federal agencies and research foundations and has published more than 270 articles in peer-reviewed journals.

A graduate of Indiana University and the IU School of Medicine and one of the Regenstrief Institute's first post-graduate trainees, Dr. Tierney has spent his 30-year career as a physician-investigator at Regenstrief and the IU School of Medicine, where he is a Chancellor's Professor and Sam Regenstrief Professor of Health Services Research. He is an associate director of the Indiana Clinical and Translational Sciences Institute.

Dr. Tierney also is chief of internal medicine for Wishard Health Services where he practices as a hospital-based internist. Wishard is the country's third largest safety net health care system and where much of Regenstrief's informatics development has taken place. He is a member of the Institute of Medicine of the National Academies of Science, a master of the American College of Physicians, a fellow of the American College of Medical Informatics and a former president of the Society of General Internal Medicine.

He has implemented and studied hospital and outpatient health informatics tools in Indiana and in Africa. He was the founding director of ResNet, one of the oldest and most productive primary care practice-based research networks in the United States.

Dr. Tierney's research has focused on implementing electronic health record systems (EHRs) in hospitals and outpatient clinics both in Indiana and in East Africa, where his team of developers implemented sub-Saharan Africa's first ambulatory EHR. It has grown to a comprehensive EHR that supports a network of more than 50 primary-care clinics in Kenya. This EHR now contains more than 100 million observations derived from more than 3 million visits by more than 300,000 patients. With help from developers at the Regenstrief Institute, Partners in Health, and the Research Council of South Africa, the system was the model for the open-source 'OpenMRS,' the most widely implemented EHR in the developing world.


'/>"/>

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-274-7722
Indiana University School of Medicine
Source:Eurekalert  

Related medicine news :

1. Regenstrief Institute to help improve disability determination through health information technology
2. RXplore: New Regenstrief tool lets docs instantly track down drug reactions
3. Measuring success: Regenstrief helps assess value of investment in health info tech
4. Regenstrief releasing new version of lingua franca needed for electronic health info exchange
5. IU and Regenstrief address critical need for health IT professionals
6. IU-Regenstrief programs targeted to alleviate shortage of health IT workforce
7. Innovation at Regenstrief: Leveraging novel ideas to improve health care
8. AMIA honors Regenstrief Institutes President and CEO with 2011 Morris F. Collen Award
9. Medical Training School, Pima Medical Institute Offering First Bachelor's Degree Program
10. Dana-Farber and Sanford-Burnham Institute license flu-targeting antibodies to Genentech and Roche
11. Laser Spine Institute Honored at the Gridiron Greats Night of Champions
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Regenstrief Institute president to receive national recognition
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: